|
ADVB Advanced Biomed Inc 1941029 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-488,942.00 |
| Balance Sheet |
|
Current Assets
|
$10,526,309.00 |
|
Assets
|
$10,646,324.00 |
|
Current Liabilities
|
$1,425,684.00 |
|
Liabilities
|
$1,436,587.00 |
|
Equity
|
$9,209,737.00 |
|
Shares Out
|
1382133.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,363,675.00 |
|
Investing Cash Flow
|
$-15,941.00 |
| Market Analysis |
Market Cap
|
$13,931,900.64 |
|
Price
|
$8.40 |
|
BVPS
|
6.66 |
|
PB
|
1.51 |
|
EPS
|
-0.38 |
|
PE
|
0.91 |
|
FCF
|
$-1,379,616.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADVB documents filed with the SEC.
ADVB Filings
Clear
